But in an established tumour, TGF-β exerts an effect which is favourable for the survival, progression and metastasis of the tumour [5,6] by promoting epithelial-mesenchymal transition (EMT), angiogenesis and escape from immune surveillance [7]. The gene discussed is TGFB1; the disease is neoplasm.